2024年至2032年牛结核病诊断市场机会、成长动力、产业趋势分析与预测

2023年，全球牛结核病诊断市场达到7.955亿美元，预计2024年至2032年复合年增长率为7.5%。

严格的政府法规和积极主动的倡议是市场的关键驱动力，世界各地的当局都实施了更严格的检测方案来遏制牛结核病的传播。此外，乳製品消费量的增加正在推动对更健康牛群的需求，使得全面的牛结核病诊断对于保障公众健康至关重要。

市场分为两大类：产品和服务。该产品领域占最大份额，预计在预测期内复合年增长率为 7.4%。这种主导地位归因于广泛的诊断工具，例如 PCR 检测、结核菌素皮肤测试和 ELISA 试剂盒。持续的研究和开发工作正在增强这些工具的有效性。此外，即时检测的创新和诊断实验室自动化的整合正在进一步加速该领域的成长。

市场也依样本类型细分，包括血液、鼻拭子、组织样本等。 2023 年，血液样本占据了最大的市场份额，达到 55.4%。血清学检测可检查血液中的特定抗体或抗原，可提供可靠且快速的结果，使其成为早期检测和及时干预的首选方法。血液采样的非侵入性及其简单性也有助于其在常规监测和检测项目中的广泛应用。

预计 2024 年至 2032 年，美国牛结核病诊断产业将以 6.9% 的复合年增长率成长。该市场的成长是由诊断技术的进步和监测能力的增强所推动的。 PCR和新一代定序等分子检测方法的引入提高了牲畜结核病检测的诊断准确性和效率。采用先进的诊断工具和全面的筛检计划，可以更轻鬆地及早发现疾病，确保更好地控制和管理疫情。这些技术进步和加强的监测实践使美国成为全球牛结核病诊断市场的关键参与者。

目录

第 1 章：方法与范围

第 2 章：执行摘要

第 3 章：产业洞察

• 产业生态系统分析
• 产业影响力
  • 成长动力
    • 牛结核病率上升
    • 诊断技术的研究与开发
    • 政府支持和倡议
    • 乳製品消费增加
  • 产业陷阱与挑战
    • 缺乏标准化的诊断方案
• 成长潜力分析
• 未来市场趋势
• 技术景观
• 监管环境
• 波特的分析
• PESTEL分析

第 4 章：竞争格局

• 介绍
• 公司市占率分析
• 公司矩阵分析
• 主要市场参与者的竞争分析
• 竞争定位矩阵
• 战略仪表板

第 5 章：市场估计与预测：按类型，2021 - 2032

• 主要趋势
• 产品
• 服务
  • 结核菌素皮肤试
    • 比较子宫颈测试 (CCT)
    • 单次皮内测试 (SIT)
    • 单子宫颈测试 (SCT) 或尾部（尾部）折迭测试 (CFT)
  • 基于血液的化验测试
    • γ 干扰素 (IFN-Y) 测定
    • 酵素连结免疫吸附测定法 (ELISA)
    • 其他基于血液的化验测试
  • 分子诊断测试

第 6 章：市场估计与预测：按样本类型，2021 - 2032 年

• 主要趋势
• 血液样本
• 鼻拭子
• 组织样本
• 其他样品

第 7 章：市场估计与预测：按最终用途，2021 - 2032 年

• 主要趋势
• 兽医院
• 科学研究机构
• 兽医诊断实验室
• 畜牧农场和牧场

第 8 章：市场估计与预测：按地区划分，2021 - 2032 年

• 主要趋势
• 北美洲
  • 我们
  • 加拿大
• 欧洲
  • 德国
  • 英国
  • 法国
  • 西班牙
  • 义大利
  • 荷兰
• 亚太地区
  • 中国
  • 日本
  • 印度
  • 澳洲
  • 韩国
• 拉丁美洲
  • 巴西
  • 墨西哥
  • 阿根廷
• 中东和非洲
  • 南非
  • 沙乌地阿拉伯
  • 阿联酋

第 9 章：公司简介

• Bio-Rad Laboratories
• Chembio Diagnostics
• Enfer
• IDEXX Laboratories
• IDVet
• LIONEX
• PBD Biotech
• QIAGEN
• Thermo Fisher Scientific
• ZENDAL

The Global Bovine Tuberculosis Diagnosis Market reached USD 795.5 million in 2023 and is projected to expand at 7.5% CAGR from 2024 to 2032. This growth is largely driven by the increasing prevalence of bovine tuberculosis worldwide and significant innovations in diagnostic technology.

Strict government regulations and proactive initiatives are key drivers for the market, with authorities worldwide implementing more rigorous testing protocols to curb the spread of bovine tuberculosis. Furthermore, the rising consumption of dairy products is boosting the demand for healthier cattle populations, making comprehensive bovine tuberculosis diagnostics essential for safeguarding public health.

The market is divided into two main categories: products and services. The product segment holds the largest share and is expected to grow at a CAGR of 7.4% during the forecast period. This dominance is attributed to a wide range of diagnostic tools, such as PCR assays, tuberculin skin tests, and ELISA kits. Continuous research and development efforts are enhancing the effectiveness of these tools. Moreover, innovations in point-of-care testing and the integration of automation in diagnostic laboratories are further accelerating growth in this segment.

The market is also segmented by sample type, which includes blood, nasal swabs, tissue samples, and others. Blood samples held the largest market share at 55.4% in 2023. This dominance is due to the effectiveness of blood samples in detecting Mycobacterium bovis, the causative agent of bovine tuberculosis. Serological tests, which examine blood for specific antibodies or antigens, provide reliable and quick results, making them the preferred method for early detection and timely intervention. The non-invasive nature of blood sampling, combined with its simplicity, also contributes to its widespread use in routine surveillance and testing programs.

The U.S. bovine tuberculosis diagnosis industry is expected to grow at a CAGR of 6.9% from 2024-2032. The growth in this market is driven by advancements in diagnostic techniques and enhanced surveillance capabilities. The introduction of molecular testing methods, such as PCR and next-generation sequencing, has improved diagnostic accuracy and efficiency in detecting tuberculosis in livestock. The adoption of advanced diagnostic tools and comprehensive screening programs has made it easier to detect the disease early, ensuring better control and management of outbreaks. These technological advancements and strengthened surveillance practices position the U.S. as a key player in the global bovine tuberculosis diagnosis market.

Table of Contents

Chapter 1 Methodology & Scope

• 1.1 Market scope & definitions
• 1.2 Research design
  • 1.2.1 Research approach
  • 1.2.2 Data collection methods
• 1.3 Base estimates & calculations
  • 1.3.1 Base year calculation
  • 1.3.2 Key trends for market estimation
• 1.4 Forecast model
• 1.5 Primary research and validation
  • 1.5.1 Primary sources
  • 1.5.2 Data mining sources

Chapter 2 Executive Summary

• 2.1 Industry 360° synopsis

Chapter 3 Industry Insights

• 3.1 Industry ecosystem analysis
• 3.2 Industry impact forces
  • 3.2.1 Growth drivers
    • 3.2.1.1 Rising prevalence of bovine tuberculosis
    • 3.2.1.2 Research and development in diagnostic techniques
    • 3.2.1.3 Government support and initiatives
    • 3.2.1.4 Increasing consumption of dairy products
  • 3.2.2 Industry pitfalls & challenges
    • 3.2.2.1 Lack of standardized diagnostic protocols
• 3.3 Growth potential analysis
• 3.4 Future market trends
• 3.5 Technology landscape
• 3.6 Regulatory landscape
• 3.7 Porter's analysis
• 3.8 PESTEL analysis

Chapter 4 Competitive Landscape, 2023

• 4.1 Introduction
• 4.2 Company market share analysis
• 4.3 Company matrix analysis
• 4.4 Competitive analysis of major market players
• 4.5 Competitive positioning matrix
• 4.6 Strategy dashboard

Chapter 5 Market Estimates and Forecast, By Type, 2021 - 2032 ($ Mn)

• 5.1 Key trends
• 5.2 Product
• 5.3 Services
  • 5.3.1 Tuberculin skin test
    • 5.3.1.1 Comparative Cervical Test (CCT)
    • 5.3.1.2 Single Intradermal Test (SIT)
    • 5.3.1.3 Single Cervical Test (SCT) or Caudal (tail) Fold Test (CFT)
  • 5.3.2 Blood-based assay test
    • 5.3.2.1 Gamma Interferon (IFN-Y) assay
    • 5.3.2.2 Enzyme-linked Immunosorbent Assay (ELISA)
    • 5.3.2.3 Other blood-based assay test
  • 5.3.3 Molecular diagnostics tests

Chapter 6 Market Estimates and Forecast, By Sample Type, 2021 - 2032 ($ Mn)

• 6.1 Key trends
• 6.2 Blood sample
• 6.3 Nasal swabs
• 6.4 Tissue sample
• 6.5 Other samples

Chapter 7 Market Estimates and Forecast, By End Use, 2021 - 2032 ($ Mn)

• 7.1 Key trends
• 7.2 Veterinary hospitals
• 7.3 Research institutes
• 7.4 Veterinary diagnostic laboratories
• 7.5 Livestock farms and ranches

Chapter 8 Market Estimates and Forecast, By Region, 2021 - 2032 ($ Mn)

• 8.1 Key trends
• 8.2 North America
  • 8.2.1 U.S.
  • 8.2.2 Canada
• 8.3 Europe
  • 8.3.1 Germany
  • 8.3.2 UK
  • 8.3.3 France
  • 8.3.4 Spain
  • 8.3.5 Italy
  • 8.3.6 Netherlands
• 8.4 Asia Pacific
  • 8.4.1 China
  • 8.4.2 Japan
  • 8.4.3 India
  • 8.4.4 Australia
  • 8.4.5 South Korea
• 8.5 Latin America
  • 8.5.1 Brazil
  • 8.5.2 Mexico
  • 8.5.3 Argentina
• 8.6 Middle East and Africa
  • 8.6.1 South Africa
  • 8.6.2 Saudi Arabia
  • 8.6.3 UAE

Chapter 9 Company Profiles

• 9.1 Bio-Rad Laboratories
• 9.2 Chembio Diagnostics
• 9.3 Enfer
• 9.4 IDEXX Laboratories
• 9.5 IDVet
• 9.6 LIONEX
• 9.7 PBD Biotech
• 9.8 QIAGEN
• 9.9 Thermo Fisher Scientific
• 9.10 ZENDAL